Eurogin is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Satellite Symposium
SEEGENE
Friday, February 10, 2023 • 12.00 - 13.15
Impact of Enhanced Information Using a New Assay for HPV Primary Screening
Chair: Kate Cuschieri (UK)
Seegene Inc. perceives this opportunity as a chance to freely discuss advanced healthcare caused by the impact of enhanced information using our new assay for HPV primary screening. This session will be led by Dr. Kate Cuschieri of the Royal Infirmary of Edinburgh (RIE, Scotland) and will focus on presenting research findings on comprehensive cervical cancer screening systems and the efficiency of HPV type and Ct value in screening.
Welcome remark
Kate Cuschieri (UK)
Clinical validation of Allplex HPV HR detection test for cervical cancer screening
Anja Ostrbenk (Slovenia)
Real-world evidences from HPV genotyping in cervical cancer screening in North region Portugal
Hugo Sousa (Portugal)
Moving forward: the value of HPV testing and genotyping in the new cervical cancer screening paradigm
Marta Del Pino (Spain)
Round table and discussion (with Q&A)
Moderator: Kate Cuschieri (UK)
Closing remark
Kate Cuschieri (UK)
Copyright © 2023. All rights reserved. Informa Markets, a trading division of Informa PLC.